On Dec. 21, the New York Mets were declared by many as the winners of the offseason after they agreed to terms with Carlos Correa, one of the top infielders in baseball, on a 12-year, $315 million contract. The Mets, who won 101 games in 2022, were adding an all-around superstar in what they hoped was the final piece in team owner Steven Cohen’s championship puzzle.
The Mets deal, which came after Correa’s 13-year, $350 million deal with the San Francisco Giants the week before unraveled, was "pending a physical examination,” contract language that is often glossed over like the "terms and conditions” on a website.
Twenty days later, however, Correa, 28, a shortstop, walked away from that deal as well. On Tuesday, he reached an agreement with the Minnesota Twins, whom he played for last season, on a six-year, $200 million contract. A personal familiar with the details of the negotiations confirmed Correa’s deal with the Twins on condition of anonymity.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.